The 2020 Digital Learning Journey on Growth Disorders

The 2021 Digital Learning Journey on Growth Disorders


Growth is one of the most important health markers during childhood, and auxological follow-up is a milestone of good clinical practice for pediatricians worldwide. Indeed, many acquired or congenital diseases might initially present only with poor weight and/or height gain. Conversely, some congenital disorders might present with non-specific signs and only affect growth in the peripubertal and pubertal stages, leading to short adult stature if not diagnosed and treated in time. Modern genetic techniques are a valuable resource for healthcare professionals diagnosing an ever-increasing number of rare conditions, with a science-based approach to managing a correct differential diagnosis crucial for saving both time and resources. Furthermore, the development of new medical treatments may allow an improvement in the quality of life and life expectancy of many patients, while possibly requiring education/training for caregivers. Turner syndrome, Prader-Willi syndrome and SHOX-gene deficiency are three rare diseases affecting not only growth, but also many other important aspects of a child’s life, such as fertility, neuropsychomotor development, longevity, sociability and interaction with their peers and, last but not least, their families’ quality of life. Therapy with recombinant human growth hormone is effective in improving growth, bone health, muscle tone, and body weight composition in children affected by these complex disorders. Pediatricians, pediatric endocrinologists and nurses are of primary importance in the multidisciplinary care of these children and in promoting continuing medical education and research.

This high-level Digital Learning Journey explores these three challenging growth disorders, paying particular attention to the importance of continuing care during the transition period from pediatric services to adult care. The role of telematic tools are essential to offer healthcare providers continuing medical education activities with practical implications for patients’ lives. In an era of serious world events affecting travel between nations, this collaboration between some of the world’s top experts in growth disorders provides content of the very highest standard directly to your computer.


These e-learning activities are intended for Pediatric Endocrinologists, Scientists, Pediatricians and Pediatric Nurses and all healthcare providers involved in the care of diseases affecting growth in childhood.


This learning journey is a structured e-learning educational program comprising:

  • Video interview: Live webinar: Prader-Willi syndrome is a life-long condition – challenges and best practice solutions for each life stage – LAUNCH: 18 June 2021
  • Live webinar: Prader-Willi syndrome is a life-long condition – challenges and best practice solutions for each life stage LAUNCH: 18 June 2021
  • Congress report: ESPE 2021 Online (22‒26 September 2021) – LAUNCH: 31 October 2021
  • Interactive clinical case: SHOX-gene deficiency and short stature – LAUNCH: 15 December 2021

For information about the program, please contact:

T +39 380 1504116 – F +39 06 4827169

This educational program is made possible thanks to an independent educational grant received from Merck Healthcare KGaA, Darmstadt, Germany